The Oral Tranexamic Acid Market is gaining momentum as healthcare providers increasingly rely on antifibrinolytic drugs to manage a wide range of bleeding disorders. These include hereditary conditions such as hemophilia-related bleeding episodes, trauma-induced hemorrhage, and post-surgical bleeding complications. Oral tranexamic acid is recognized for its ability to stabilize blood...